收费全文 | 5978篇 |
免费 | 341篇 |
国内免费 | 36篇 |
耳鼻咽喉 | 50篇 |
儿科学 | 133篇 |
妇产科学 | 102篇 |
基础医学 | 870篇 |
口腔科学 | 499篇 |
临床医学 | 428篇 |
内科学 | 1343篇 |
皮肤病学 | 142篇 |
神经病学 | 474篇 |
特种医学 | 156篇 |
外科学 | 565篇 |
综合类 | 37篇 |
一般理论 | 1篇 |
预防医学 | 530篇 |
眼科学 | 138篇 |
药学 | 591篇 |
中国医学 | 56篇 |
肿瘤学 | 240篇 |
2023年 | 55篇 |
2022年 | 125篇 |
2021年 | 204篇 |
2020年 | 125篇 |
2019年 | 167篇 |
2018年 | 221篇 |
2017年 | 142篇 |
2016年 | 146篇 |
2015年 | 168篇 |
2014年 | 255篇 |
2013年 | 298篇 |
2012年 | 456篇 |
2011年 | 487篇 |
2010年 | 279篇 |
2009年 | 212篇 |
2008年 | 363篇 |
2007年 | 375篇 |
2006年 | 283篇 |
2005年 | 279篇 |
2004年 | 255篇 |
2003年 | 196篇 |
2002年 | 165篇 |
2001年 | 120篇 |
2000年 | 119篇 |
1999年 | 100篇 |
1998年 | 38篇 |
1997年 | 34篇 |
1996年 | 31篇 |
1995年 | 26篇 |
1994年 | 30篇 |
1993年 | 25篇 |
1992年 | 54篇 |
1991年 | 43篇 |
1990年 | 43篇 |
1989年 | 48篇 |
1988年 | 34篇 |
1987年 | 29篇 |
1986年 | 25篇 |
1985年 | 28篇 |
1984年 | 13篇 |
1983年 | 14篇 |
1979年 | 19篇 |
1978年 | 16篇 |
1974年 | 17篇 |
1973年 | 22篇 |
1971年 | 13篇 |
1970年 | 14篇 |
1969年 | 16篇 |
1967年 | 14篇 |
1922年 | 13篇 |
Background:
This study tested the hypothesis that the low-grade inflammation presented in patients with bipolar disorder (BD) is associated with expansion of activated T cells, and this activated state may be due to a lack of peripheral regulatory cells.Methods:
Specifically, we investigated the distribution of monocytes and lymphocyte subsets, and investigated Th1/Th2/Th17 cytokines in plasma by flow cytometry. Twenty-one BD type I patients and 21 age- and sex-matched controls were recruited for this study.Results:
BD patients had increased proportions of monocytes (CD14+). Regarding lymphocyte populations, BD patients presented reduced proportions of T cells (CD3+) and cytotoxic T cells (CD3+CD8+). BD patients also exhibited a higher percentage of activated T CD4+CD25+ cells, and a lower percentage of IL-10 expressing Treg cells.Conclusions:
Our data shed some light into the underlying mechanisms involved with the chronic low-grade inflammatory profile described in BD patients. 相似文献Since HLA-G is an immune checkpoint molecule and since Crohn’s disease (CD) and ulcerative colitis (UC) exhibit deregulated immune-mediated mechanisms, we aimed to evaluate intestinal HLA-G expression and soluble HLA-G (sHLA-G) levels in CD/UC patients stratified according to the CD phenotype/localization and UC extension.
MethodsHLA-G tissue expression was assessed by immunohistochemistry in biopsies collected from 151 patients (90 CD, 61 UC) and in surgical resection specimens (28 CD, 12 UC). Surgical material from 24 healthy controls was also assessed. Plasma sHLA-G levels (97 CD, 81 UC, and 120 controls) were evaluated using ELISA.
ResultsHLA-G expression was similarly observed in the intestinal epithelial cells of control and CD/UC specimens. However, in biopsies, the plasma cells/lymphocytes infiltrating the lamina propria in CD/UC presented (1) increased HLA-G expression compared to controls (P?<?0.0001), (2) greater cell staining in UC cells than in CD cells irrespective of disease extent (P?=?0.0011), and (3) an increased number of infiltrating cells in the inflammatory CD phenotype compared to that in the stenosing and fistulizing phenotypes (P?=?0.0407). In surgical specimens, CD/UC patients exhibited higher infiltrating cell HLA-G expression in lesion areas than in margins. sHLA-G levels were higher in UC/CD patients (P?<?0.0001) than in controls, but no difference was observed between diseases.
ConclusionsIncreased infiltrating cell HLA-G expression associated with increased sHLA-G levels in CD/UC patients may reflect ongoing host strategies to suppress chronic inflammation.
相似文献